Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1998
11/11/1998CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
11/10/1998US5834593 Genetic engineering of prion protein
11/10/1998US5834510 Topical application
11/10/1998US5834485 Quinoline sulfonamides and their therapeutic use
11/10/1998US5834479 Method and composition for alleviating pain
11/10/1998US5834470 Decongestants; bronchodilator and antisecretory and -tussive agents; side effect reduction
11/10/1998US5834465 Treatment with combined NMDA and non-NMDA antagonists to reduce excitotoxic CNS damage
11/10/1998US5834444 Hyaluronic acid and salts thereof inhibit arterial restenosis
11/10/1998US5834432 Use of angiotensin II Type 2 receptor agonists in tissue repair
11/10/1998US5834419 Chemokine binding protein and methods of use therefor
11/10/1998US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5834044 Provides enhanced in vivo oxidative defense indices and prevents or attenuates exercise induced in vivo oxidative stress
11/10/1998US5834025 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
11/10/1998US5834008 Composition and method for acceleration of wound and burn healing
11/10/1998US5834002 Water insoluble gum base with water soluble bulk portion, flavors, colloidal bismuth salts of hydroxy carboxylic aicds, for treating helicobacter pylori infections, antiulcer agents
11/10/1998US5833987 Treatment of T cell mediated autoimmune disorders
11/10/1998US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049293A1 Human theta subunit of the gaba-a receptor
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049135A1 Compounds and compositions for delivering active agents
11/05/1998WO1998048839A1 Topical nasal antiinflammatory compositions
11/05/1998WO1998048836A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant
11/05/1998WO1998048828A1 Method of treating sepsis
11/05/1998WO1998048827A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/05/1998WO1998048825A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998WO1998048816A1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
11/05/1998WO1998048813A1 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells
11/05/1998WO1998048810A1 Composition and methods using an eutomer
11/05/1998WO1998048809A1 Use of immunomodulating agents
11/05/1998WO1998048796A1 Use of melatonin for preparing medicaments for treating circadian rhythm phase disorders
11/05/1998WO1998048795A1 Therapeutic treatment for skin disorders
11/05/1998WO1998048789A1 Pharmaceutical compositions of arglabin and arglabin derivatives
11/05/1998WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998WO1998048784A2 Method and composition for modulating amyloidosis
11/05/1998WO1998048780A1 Vesicular complexes and methods of making and using the same
11/05/1998WO1998048630A1 Method of treating malignancies
11/05/1998WO1998048627A1 Teat dipping agent
11/05/1998WO1998034954A3 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
11/05/1998WO1998033920A3 Tissue factor pathway inhibitor-3
11/05/1998WO1998031799A3 Polynucleotides and polypeptides encoding receptors
11/05/1998CA2539919A1 Compositions of aminosugars or fragments of glycosaminoglycans with s-adenosylmethionine for the treatment or repair of connective tissue in mammals
11/05/1998CA2539696A1 Compositions of aminosugars, glycosaminoglycans and s-adenosylmethionine for the treatment or repair of connective tissue in mammals
11/05/1998CA2289257A1 Therapeutic treatment for skin disorders
11/05/1998CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998CA2288138A1 Compounds and compositions for delivering active agents
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287976A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant
11/05/1998CA2287910A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998CA2287877A1 Method of treating sepsis
11/05/1998CA2287782A1 Human theta subunit of the gaba-a receptor
11/05/1998CA2287318A1 Pharmaceutical compositions of arglabin and arglabin derivatives
11/05/1998CA2285948A1 Method and composition for modulating amyloidosis
11/05/1998CA2281789A1 Topical nasal antiinflammatory compositions
11/05/1998CA2259327A1 Teat dipping agent
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875246A1 Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer
11/04/1998EP0874905A1 Novel tcts response regulator of staphylococcus aureus
11/04/1998EP0874637A1 Therapeutic applications of t-bam (cd40l) technology to treat inflammatory kidney diseases
11/04/1998EP0874634A1 Control of healing process
11/04/1998EP0874630A1 Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy
11/04/1998EP0874626A1 Use of inhibitors of retinoic acid activity for wound healing
11/04/1998CN1198165A Modulators of function of FAS receptors and other proteins
11/04/1998CN1040505C Method for prep. of antihypertensive composition
11/03/1998US5831066 B-CELL LYMPHOMA/LEUKEMIA GENE (bcl-2); ANTISENSE AGENT COMPRISING A SYNTHETIC 18 BASE PHOSPHOROTHIOATE OLIGONUCLEOTIDE; ANTICANCER AGENT, OBLIMERSEN; ANTICANCER AGENT; SENSITIZING TUMOR CELLS TO CHEMOTHERAPY
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831031 Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
11/03/1998US5831017 Divalent metal complex
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5830895 Methods for the determination and adjustment of prolactin daily rhythms
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830874 Compositions and methods for the treatment of arterial chlamydial granuloma
11/03/1998US5830870 Prevent loss of muscle mass
11/03/1998US5830850 Methods for the treatment of bone resorption disorders, including osteoporosis
11/03/1998US5830646 Diagnostic method
11/03/1998US5830508 Composition for treating dry eye
11/03/1998US5830461 Methods for promoting wound healing and treating transplant-associated vasculopathy
11/03/1998US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
11/03/1998US5830454 Mouse models of human disease
11/03/1998US5830448 Compositions and methods for the treatment of tumors
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048264A1 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
1 ... 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 ... 1151